NCT07405801
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07405801
Title A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior
Covered Countries CAN | BRA

Facility Status City State Zip Country Details
Hospital Brasilia RECRUITING Brasília Federal District 71.635-610 Brazil Details
ICTR Curitiba RECRUITING Curitiba Paraná 80510-130 Brazil Details
Hospital Santa Rita de Cassia Vitoria RECRUITING Curitiba Pará 80810-050 Brazil Details
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda RECRUITING São Paulo São Paulo 01317-000 Brazil Details
CIUSSS du Saguenay Lac-Saint-Jean, Chicoutimi Hospital RECRUITING Chicoutimi Quebec G7H 5H6 Canada Details
McGill University RECRUITING Montreal Quebec H4A 3J1 Canada Details
Soon Chun Hyang University Cheonan Hospital RECRUITING Dongnam-gu, Cheonan-si 31151 South Korea Details
Gachon University Gil Medical Center RECRUITING Namdong-Gu 21565 South Korea Details
Seoul National University Bundang Hospital RECRUITING Seongnam-si 13605 South Korea Details
Seoul National University Hospital RECRUITING Seoul 03080 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field